Baidu
map

J. Neurosci:遗传发育所脑肿瘤抑制因子调控突触发育研究获进展

2013-07-29 遗传与发育生物学研究所 遗传与发育生物学研究所

神经突触是神经元与其靶细胞之间进行信息交流的特化结构。突触生长过程的精确调控对于神经环路的形成和可塑性至关重要,突触发育和功能的异常导致多种神经精神疾病包括智力低下、自闭症、精神分裂症和神经变性病等。因此,寻找和鉴定突触发育和功能调控基因一直是神经生物学家的重要研究内容之一。 果蝇脑肿瘤基因brat(brain tumor)是一个进化上非常保守的基因,该基因突变后导致果蝇大脑产生肿瘤,造成大脑半

神经突触是神经元与其靶细胞之间进行信息交流的特化结构。突触生长过程的精确调控对于神经环路的形成和可塑性至关重要,突触发育和功能的异常导致多种神经精神疾病包括智力低下、自闭症、精神分裂症和神经变性病等。因此,寻找和鉴定突触发育和功能调控基因一直是神经生物学家的重要研究内容之一。

果蝇脑肿瘤基因brat(brain tumor)是一个进化上非常保守的基因,该基因突变后导致果蝇大脑产生肿瘤,造成大脑半球明显增大。中国科学院遗传与发育生物学研究所张永清实验室通过多学科的实验手段的研究发现,brat突变体的神经肌肉突触过度生长,其显著特征是突触卫星扣结数大大增加。同时,电镜实验结果表明,与野生型相比,brat突变体突触扣结负责神经递质传递的活性区的大小增大。电生理测试结果表明,brat突变导致自发性的微兴奋性突触后电位升高,突触传递效率下降。并且,FM1-43荧光染料内吞实验显示brat突变体的突触内吞功能受损,表明Brat参与调控突触内吞功能。遗传学互作及生化实验表明,发现brat通过抑制BMP (Bone Morphogenic Protein)信号途径中转录因子Mad(Mothers against decapentaplegic)的表达,从而调控了神经肌肉突触的形态、结构和功能。该研究结果揭示,脑肿瘤蛋白Brat除了在神经系统早期分化发育过程起重要作用外,在已成熟的神经元的突触生长过程中也起着关键作用。该研究将有助于进一步认识突触发育的分子调控机制以及神经系统相关疾病的发病机制。

该研究结果于7月24日正式发表在国际学术期刊Journal of Neuroscience。张永清课题组的博士生石文文和陈严为该论文的共同第一作者。合作实验室包括中科院遗传发育所的许执恒研究员实验室和东南大学的谢维教授实验室。

该研究得到了国家自然科学基金委和中科院的资助。

Current Issue

Shi W, Chen Y, Gan G, Wang D, Ren J, Wang Q, Xu Z, Xie W, Zhang YQ.Brain tumor regulates neuromuscular synapse growth and endocytosis in Drosophila by suppressing mad expression.J Neurosci. 2013 Jul 24;33(30):12352-63. doi: 10.1523/JNEUROSCI.0386-13.2013.PMID: 23884941

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
    2013-07-31 neurowu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
    2013-07-31 lsndxfj
  6. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1809120, encodeId=4da5180912045, content=<a href='/topic/show?id=a68f829380b' target=_blank style='color:#2F92EE;'>#肿瘤抑制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82938, encryptionId=a68f829380b, topicName=肿瘤抑制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Sun Jan 12 13:34:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718786, encodeId=3c941e18786dc, content=<a href='/topic/show?id=ea4782939b8' target=_blank style='color:#2F92EE;'>#肿瘤抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82939, encryptionId=ea4782939b8, topicName=肿瘤抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1b32641457, createdName=lxg962, createdTime=Thu Apr 10 06:34:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801190, encodeId=a020180119073, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Nov 17 04:34:00 CST 2013, time=2013-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346996, encodeId=fc521346996c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363894, encodeId=9aee136389425, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417982, encodeId=7cb8141e982e7, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478769, encodeId=609114e8769ce, content=<a href='/topic/show?id=76efe555021' target=_blank style='color:#2F92EE;'>#突触#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75550, encryptionId=76efe555021, topicName=突触)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5207457717, createdName=ms691033630344116, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532068, encodeId=45641532068e2, content=<a href='/topic/show?id=43d454921d1' target=_blank style='color:#2F92EE;'>#抑制因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54921, encryptionId=43d454921d1, topicName=抑制因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e90612318044, createdName=shalley70, createdTime=Wed Jul 31 00:34:00 CST 2013, time=2013-07-31, status=1, ipAttribution=)]

相关资讯

NAT MED:新技术利用葡萄糖诊断癌症类型

日前,伦敦大学学院(UCL)的研究人员发现,一种用于检测肿瘤中非放射性葡萄糖分子摄入情况的无损技术能帮助诊断癌症类型并评估病人的治疗反应。相关研究论文刊登在了近期出版的《自然-医学》(Nature Medicine)杂志上。 与正常组织相比,肿瘤需要摄入更多的葡萄糖以产生能量和制造细胞增殖所需的阻断物。 研究人员开发的这项技术被称为葡萄糖化学交换饱和转移(glucoCEST),同其他黄金标

中国成功实施新型晚期肝癌切除术

  7月18日,新型肝脏肿瘤切除手术在四川省人民医院成功实施。 沈依宣 摄   7月18日,四川省人民医院器官移植中心成功实施了一种全新的肝癌切除手术,目前患者病情稳定。这标志着我国晚期肝肿瘤的根治性手术取得新的进展。   据了解,这种手术于2012年在德国首创,正式名称为联合肝脏分割和门静脉结扎的分阶段肝切除术,简称ALPPS,是晚期肝肿瘤的根治性手术。   据院方介绍,49岁

Nature:癌细胞的多样性

肿瘤是由各种不同的细胞类群组成的,这往往会导致治疗失败,理解这种癌症异质性将能改善化疗的治疗疗效。 细胞具有不同的形状和大小,有四四方方的上皮细胞,圆饼状的红细胞,细长丝状的神经细胞,还有巨大的肉眼可见的人类卵细胞。即使是相同基本类型的细胞,也没有两个是完全一样的,同样癌变的肿瘤细胞中也是如此,这里充斥着各种不同大小和形状的细胞,这对患者癌症的发展具有重要的影响。因此,研究人员希望能掌握细胞异质

十二指肠乳头肿瘤局部切除术成功治疗及体会

      疾病概述   十二指肠乳头部肿瘤发病率约占消化道肿瘤的1%。主要包括: 腺瘤、腺癌、家族性腺瘤性息肉病以及其他发病率很低的类癌、黑色素瘤、肾上腺样瘤、肉瘤、间质瘤、神经纤维瘤、淋巴瘤及平滑肌瘤等。   由于其病变部位较特殊,早

复杂性“孤立肾”肿瘤1例及病例讨论

  病例简介   病史   男性患者,64岁。半年前反复出现右侧腰背胀痛,无肉眼血尿及尿频、尿急、尿痛,当地医院腹部彩色超声和CT检查提示:右肾下极囊实性占位,约55 mm×45 mm×40 mm,肾癌不除外,左肾缺如。磁共振成像(MRI)示:右肾癌肿,侵出肾包膜,左肾缺如。10年前行左肾切除术,5年前行右肾盂切开取石术。   查体及辅助检查   

Nature:首次发现骨癌症干细胞

来自美国Rhode Island医院的研究人员,发现小鼠体内一些特殊软骨细胞缺失Shp-2酶,可导致多发性良性软骨肿瘤形成。这一小鼠模型重演了人类一种罕见的肿瘤综合征:混合性软骨瘤病(metachondromatosis)。研究结果发布在7月17日的《自然》(Nature)杂志上。 Shp2酶可在细胞中调控其他蛋白质和信号通路的活性。缺失Shp2的小鼠会形成两种类型的肿瘤:内生软骨瘤(

Baidu
map
Baidu
map
Baidu
map